Trademark: 97274856
Word
RIVZEPRI
Status Date
Tuesday, June 18, 2024
Filing Date
Friday, February 18, 2022
Published for Opposition
Tuesday, November 7, 2023
5 Pharmaceutical preparations for the treatment of chronic fibrotic and proliferative disorders; pharmaceutical preparations for the treatment of cancer, muscular dystrophy and idiopathic pulmonary fibrosis
Feb 22, 2022
New Application Entered
Feb 24, 2022
New Application Office Supplied Data Entered
Apr 15, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 15, 2022
Teas Change Of Correspondence Received
Apr 15, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 15, 2022
Assigned To Examiner
Aug 17, 2022
Suspension Letter Written
Aug 17, 2022
Letter Of Suspension E-Mailed
Aug 17, 2022
Notification Of Letter Of Suspension E-Mailed
Feb 21, 2023
Report Completed Suspension Check Case Still Suspended
Aug 23, 2023
Report Completed Suspension Check Case Still Suspended
Oct 2, 2023
Approved For Pub - Principal Register
Oct 18, 2023
Notification Of Notice Of Publication E-Mailed
Nov 7, 2023
Published For Opposition
Nov 7, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 2, 2024
Noa E-Mailed - Sou Required From Applicant
Jun 18, 2024
Sou Teas Extension Received
Jun 18, 2024
Notice Of Approval Of Extension Request E-Mailed
Jun 18, 2024
Sou Extension 1 Granted
Jun 18, 2024
Sou Extension 1 Filed
Trademark Alertz updated from USPTO on 2030-01-24
